Altrius Capital Management Inc Buys 7,865 Shares of Sanofi (NASDAQ:SNY)

Altrius Capital Management Inc lifted its stake in shares of Sanofi (NASDAQ:SNY) by 5.1% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 161,940 shares of the company’s stock after acquiring an additional 7,865 shares during the period. Sanofi accounts for about 2.1% of Altrius Capital Management Inc’s portfolio, making the stock its 5th largest position. Altrius Capital Management Inc’s holdings in Sanofi were worth $7,810,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Synergy Asset Management LLC bought a new stake in shares of Sanofi during the 4th quarter valued at $25,000. McClarren Financial Advisors Inc. boosted its holdings in shares of Sanofi by 952.6% during the fourth quarter. McClarren Financial Advisors Inc. now owns 600 shares of the company’s stock worth $28,000 after purchasing an additional 543 shares during the period. Sunbelt Securities Inc. boosted its holdings in Sanofi by 72.1% in the third quarter. Sunbelt Securities Inc. now owns 747 shares of the company’s stock valued at $43,000 after acquiring an additional 313 shares in the last quarter. Sierra Ocean LLC purchased a new position in shares of Sanofi during the 4th quarter worth approximately $44,000. Finally, Versant Capital Management Inc bought a new position in shares of Sanofi in the 4th quarter worth about $54,000. Institutional investors own 14.04% of the company’s stock.

Sanofi Stock Down 1.5 %

Shares of SNY opened at $54.14 on Friday. The firm has a market cap of $137.40 billion, a P/E ratio of 21.74, a PEG ratio of 1.01 and a beta of 0.57. The stock’s 50 day moving average is $51.51 and its two-hundred day moving average is $52.59. The company has a current ratio of 1.46, a quick ratio of 1.14 and a debt-to-equity ratio of 0.15. Sanofi has a 12 month low of $45.22 and a 12 month high of $58.97.

Sanofi (NASDAQ:SNY) last announced its earnings results on Thursday, January 30th. The company reported $0.70 earnings per share for the quarter, hitting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. Analysts predict that Sanofi will post 4.36 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities research analysts recently commented on SNY shares. Deutsche Bank Aktiengesellschaft raised Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. Sanford C. Bernstein raised shares of Sanofi to a “strong-buy” rating in a research note on Thursday, January 30th. Finally, StockNews.com cut shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Two investment analysts have rated the stock with a hold rating, one has given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $60.00.

Sanofi Profile

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.